Last reviewed · How we verify

NCT04904068

Functional Neuroimaging in Parkinson's Disease

Active, enrolled Last updated 6 April 2025
What this trial tests

trial in Parkinson Disease in 40 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
15 September 2020
Primary endpoint
2 November 2022
2 November 2025

Quick facts

Lead sponsorUniversity of Delaware
StatusActive, enrolled
Study typeOBSERVATIONAL
Enrollment40
Start date15 September 2020
Primary completion2 November 2022
Estimated completion2 November 2025
Sites1 location across United States

Conditions studied

Sponsor

University of Delaware

Who can join

Adults 45 to 85, any sex, with Parkinson Disease or Healthy Aging. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study uses magnetic resonance imaging (MRI) to better understand changes in the brain underlying motor symptoms affecting upper and lower limbs in Parkinson's disease.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Parkinson Disease

Currently open trials in the same condition.

Other University of Delaware trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04904068.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing